Real-world data on SGLT2 inhibitors and risk of serious renal events

Data from 29,887 new SGLT2 inhibitor users and 29,887 new DPP-4 inhibitor users.
Data from 29,887 new SGLT2 inhibitor users and 29,887 new DPP-4 inhibitor users.